glp-1 receptor agonist after bariatric surgery weight regain Interest in Treatment with Agonists for the Management of Insufficient Loss or Weight | Obesity Surgery Weight maintenance after discontinuation of
Description
This provides evidence that cardiovascular benefits from GLP-1R agonism may also come from metabolic changes in cardiac tissue through systemic signaling (Almutairi et al

Moreover, some trials revealed improvements in cardiovascular risk markers such as BNP and CRP

Previous antiobesity medications showed modest efficacy with limited long-term safety data and limited benefits beyond weight loss
doi: 10.1111/jnc.13248 [DOI] [PubMed] [Google Scholar] 162

2014;9 doi: 10.1371/journal.pone.0096863

Most providers follow the standard escalation schedule, but some patients need to move up sooner, and a few do well staying at intermediate doses longer
